Find Grants for Non-profits
Find out if you qualify for verified grants for Non-profits. Discover your eligibility and key funding details for Non-profits from major foundations and government agencies.
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Deadline: September 25, 2026
Opportunity Number: PAR-25-247
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 25, 2026
Status: Posted
CFDA Numbers: 93.866
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Deadline: September 10, 2027
Opportunity Number: PAR-25-325
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 10, 2027
Status: Posted
CFDA Numbers: 93.393
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Deadline: May 8, 2027
Opportunity Number: PAR-25-317
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: May 8, 2027
Status: Posted
CFDA Numbers: 93.313, 93.307, 93.399, 93.273, 93.310, 93.361
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: January 11, 2026
Opportunity Number: PAR-25-029
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 11, 2026
Status: Posted
CFDA Numbers: 93.840, 93.838, 93.233, 93.837, 93.839
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-346
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.393, 93.121, 93.396, 93.395, 93.399
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Deadline: July 16, 2026
Opportunity Number: PAR-25-154
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: July 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.846, 93.273, 93.865, 93.866, 93.121, 93.213, 93.279, 93.350
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
Deadline: October 15, 2027
Opportunity Number: PAR-25-277
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.847
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
Deadline: October 19, 2026
Opportunity Number: PAR-25-155
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 19, 2026
Status: Posted
CFDA Numbers: 93.350
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Deadline: January 11, 2026
Opportunity Number: PAR-25-028
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 11, 2026
Status: Posted
CFDA Numbers: 93.838, 93.233, 93.839, 93.840, 93.837
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Deadline: June 18, 2026
Opportunity Number: PAR-25-157
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: June 18, 2026
Status: Posted
CFDA Numbers: 93.350
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-321
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Deadline: June 15, 2026
Opportunity Number: RFA-EY-25-001
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: June 15, 2026
Status: Posted
CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline: November 2, 2026
Opportunity Number: PAR-24-280
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline: November 2, 2026
Opportunity Number: PAR-24-279
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: March 4, 2027
Opportunity Number: PAR-25-141
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: March 4, 2027
Status: Posted
CFDA Numbers: 93.846
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-330
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.847, 93.242, 93.855, 93.865
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-239
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
